CHTR vs. MRNA
Compare and contrast key facts about Charter Communications, Inc. (CHTR) and Moderna, Inc. (MRNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CHTR or MRNA.
Key characteristics
| CHTR | MRNA | |
|---|---|---|
| YTD Return | -34.15% | 10.92% |
| 1Y Return | -30.17% | -17.31% |
| 3Y Return (Ann) | -27.63% | -14.91% |
| 5Y Return (Ann) | -7.14% | 31.32% |
| Sharpe Ratio | -0.89 | -0.34 |
| Daily Std Dev | 34.56% | 49.85% |
| Max Drawdown | -68.99% | -85.65% |
| Current Drawdown | -68.83% | -77.23% |
Fundamentals
| CHTR | MRNA | |
|---|---|---|
| Market Cap | $36.76B | $41.34B |
| EPS | $30.88 | -$12.33 |
| PE Ratio | 8.25 | 24.73 |
| PEG Ratio | 0.28 | 0.00 |
| Revenue (TTM) | $54.63B | $6.85B |
| Gross Profit (TTM) | $24.49B | $10.55B |
| EBITDA (TTM) | $21.13B | -$3.62B |
Correlation
The correlation between CHTR and MRNA is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CHTR vs. MRNA - Performance Comparison
In the year-to-date period, CHTR achieves a -34.15% return, which is significantly lower than MRNA's 10.92% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CHTR vs. MRNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Charter Communications, Inc. (CHTR) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CHTR vs. MRNA - Dividend Comparison
Neither CHTR nor MRNA has paid dividends to shareholders.
Drawdowns
CHTR vs. MRNA - Drawdown Comparison
The maximum CHTR drawdown since its inception was -68.99%, smaller than the maximum MRNA drawdown of -85.65%. Use the drawdown chart below to compare losses from any high point for CHTR and MRNA. For additional features, visit the drawdowns tool.
Volatility
CHTR vs. MRNA - Volatility Comparison
The current volatility for Charter Communications, Inc. (CHTR) is 7.10%, while Moderna, Inc. (MRNA) has a volatility of 11.01%. This indicates that CHTR experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CHTR vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between Charter Communications, Inc. and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities